Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Danazol

Related Products

Hot Products

Name

Danazol

EINECS 241-270-1
CAS No. 17230-88-5 Density 1.21 g/cm3
PSA 46.26000 LogP 4.22100
Solubility Partly soluble in water. Soluble in chloroform (25 mg/ml), acetone, acetonitrile, and ethanol. 17beta-Hydroxy-2,4,17a-pregnadien-20-yno[2,3-d]isoxazole and 2,4,17a-Pregnadien-20-yno[2,3-d]isoxazol-17-ol are the synonym of this compound. Melting Point 224.4-226.8 °C
Formula C22H27NO2 Boiling Point 478.2 °C at 760 mmHg
Molecular Weight 337.462 Flash Point 243 °C
Transport Information N/A Appearance White solid
Safety 22-36-37/39-26 Risk Codes 20/21/22-63-36/37/38
Molecular Structure Molecular Structure of 17230-88-5 (Danazol) Hazard Symbols HarmfulXn,IrritantXi
Synonyms

17a-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol(8CI);1H-Cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol, 1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-(7CI);Bonzol;Cyclomen;Danalem;Danazolum;Danocrine;Danol;Ladogal;NSC 270916;Win 17757;Winobanin;

Article Data 5

Danazol Specification

The Danazol, with the CAS registry number 17230-88-5, is also known as 17-alpha-Pregn-4-en-20-yno(2,3-d)isoxazol-17-ol. It belongs to the product categories of Steroids; Organics; Intermediates & Fine Chemicals; Pharmaceuticals. Its EINECS registry number is 241-270-1. This chemical's molecular formula is C22H27NO2 and molecular weight is 337.5. Its systematic name is called (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol. This chemical's classification codes are Anterior pituitary suppressant; Drug / Therapeutic Agent; Estrogen Receptor Modulators; Estrogen antagonists; Hormone; Hormone Antagonists; Hormones, Hormone Substitutes, and Hormone Antagonists; Human Data; Mutation data; Reproductive Effect; Tumor data.

Physical properties of Danazol: (1)ACD/LogP: 4.70; (2)ACD/LogD (pH 5.5): 4.7; (3)ACD/LogD (pH 7.4): 4.7; (4)ACD/BCF (pH 5.5): 2202.59; (5)ACD/BCF (pH 7.4): 2202.59; (6)ACD/KOC (pH 5.5): 8599.41; (7)ACD/KOC (pH 7.4): 8599.39; (8)#H bond acceptors: 3; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 1; (11)Index of Refraction: 1.603; (12)Molar Refractivity: 95.82 cm3; (13)Molar Volume: 278.6 cm3; (14)Surface Tension: 55 dyne/cm; (15)Density: 1.21 g/cm3; (16)Flash Point: 243 °C; (17)Enthalpy of Vaporization: 78.19 kJ/mol; (18)Boiling Point: 478.2 °C at 760 mmHg; (19)Vapour Pressure: 5.94E-10 mmHg at 25°C.

Danazol is a derivative of the synthetic steroid ethisterone, a modified testosterone. Although effective for endometriosis, its use is limited by its masculinizing side-effects. Its role as a treatment for endometriosis has been largely replaced by the GnRH agonists. The agent is fat-soluble. It is an isoxazole of testosterone with isolated weak androgenic activity and no estrogenic or progestagenic effects. Danazol is contraindicated in pregnancy because it could masculinize a female fetus.

When you are using this chemical, please be cautious about it as the following:
This chemical may cause inflammation to the skin or other mucous membranes and may cause damage to health. It is harmful by inhalation, in contact with skin and if swallowed. In addition, it is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. Whenever you will contact it, please wear suitable protective clothing, gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
(2)Isomeric SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5
(3)InChI: InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1
(4)InChIKey: POZRVZJJTULAOH-LHZXLZLDSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral > 5gm/kg (5000mg/kg)   Journal of International Medical Research. Vol. 5(Suppl,
man TDLo oral 274mg/kg/32D- (274mg/kg) LIVER: "JAUNDICE, CHOLESTATIC"

LIVER: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Postgraduate Medical Journal. Vol. 69, Pg. 237, 1993.
man TDLo oral 1029mg/kg/17W (1029mg/kg) LIVER: "JAUNDICE, CHOLESTATIC" Postgraduate Medical Journal. Vol. 68, Pg. 984, 1992.
mouse LD50 intraperitoneal 6770mg/kg (6770mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 14, Pg. 484, 1983.
mouse LD50 oral 4830mg/kg (4830mg/kg)   Zhongguo Yaoxue Zazhi. Chinese Pharmacuetical Journal. Vol. 25, Pg. 55, 1990.
mouse LD50 subcutaneous > 10gm/kg (10000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 25, Pg. 691, 1983.
rabbit LD50 oral > 5gm/kg (5000mg/kg)   Journal of International Medical Research. Vol. 5(Suppl,
rat LD50 intraperitoneal > 10gm/kg (10000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 25, Pg. 691, 1983.
rat LD50 oral > 17gm/kg (17000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 25, Pg. 691, 1983.
rat LD50 subcutaneous > 10gm/kg (10000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 25, Pg. 691, 1983.
women TDLo oral 120mg/kg/10D- (120mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" Archives of Internal Medicine. Vol. 145, Pg. 2251, 1985.
women TDLo oral 974mg/kg/23W- (974mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

SENSE ORGANS AND SPECIAL SENSES: DIPLOPIA: EYE

BEHAVIORAL: HEADACHE
Therapie. Vol. 43, Pg. 501, 1988.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17230-88-5